array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "Oppenheimer Holdings Inc." ["slug"]=> string(33) "d9d67-us-oppenheimer-holdings-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/a99751a9-e5ba-47be-b7b8-15581b246381" ["description"]=> string(1060) "Oppenheimer & Co. Inc. is a leading national investment boutique with over a century of tradition. Oppenheimer’s culture of providing innovative, customized solutions to our clients sets us apart from our competitors. Oppenheimer is proud of its reputation as a Firm that helps individuals, families, corporate executives, foundations and endowments, charities, pension plans businesses, and institutions. We occupy a unique position in the industry, thanks to the dedication, expertise, and creativity of our people. Oppenheimer Financial Advisors draw on the extensive resources and expertise of nearly 1,900 other professionals, including those in Equity Research, Capital Markets, and Investment Banking. Oppenheimer Asset Management Inc., Oppenheimer Life Agency Ltd., Oppenheimer Trust Company of Delaware and Oppenheimer & Co. Inc. are wholly owned subsidiaries of Oppenheimer Holdings Inc., an integrated financial holding company. Oppenheimer is a registered broker-dealer and investment advisory firm. Securities are offered through Oppenheimer. " ["address_street"]=> string(17) "85 Broad St FL 22" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1881-02-13" ["website_domain"]=> string(8) "opco.com" ["website_url"]=> string(20) "https://www.opco.com" ["industry_codes"]=> array(3) { [0]=> string(50) "Security Brokers, Dealers, and Flotation Companies" [1]=> string(33) "Offices of Bank Holding Companies" [2]=> string(39) "Management Investment Offices, Open-End" } ["employee_count"]=> int(7) ["article_count"]=> int(321) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(146) "Jasper Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares" ["snippet_en"]=> string(152) "REDWOOD CITY, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on..." ["url"]=> string(215) "https://www.globenewswire.com/news-release/2023/01/27/2597057/0/en/Jasper-Therapeutics-Announces-Closing-of-Public-Offering-of-Common-Stock-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a5d4a756-0809-4622-84a2-32c07b589008" ["source"]=> string(17) "globenewswire.com" ["publication_date"]=> string(10) "2023-01-27" ["categories"]=> array(2) { [0]=> string(12) "Going Public" [1]=> string(25) "Business Model Resilience" } } [1]=> array(7) { ["title_en"]=> string(126) "Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million" ["snippet_en"]=> string(126) "Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million" ["url"]=> string(55) "https://technews.tmcnet.com/news/2022/12/07/9725935.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/630bf0bd-19f0-4921-bd41-1878f032cfb3" ["source"]=> string(10) "tmcnet.com" ["publication_date"]=> string(10) "2022-12-07" ["categories"]=> array(3) { [0]=> string(17) "Commodity Pricing" [1]=> string(12) "Going Public" [2]=> string(12) "Slash Prices" } } [2]=> array(7) { ["title_en"]=> string(88) "Saratoga Investment Corp. Prices Public Offering of $52.5 Million 8.125% Notes Due 2027" ["snippet_en"]=> string(302) "NEW YORK, NY , Dec. 05, 2022 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (the “Company”) (NYSE: SAR) today announced that it has priced an underwritten public offering of $52.5 million in aggregate principal amount of 8.125% unsecured notes due 2027 (the “Notes”). The Notes will mature on" ["url"]=> string(147) "https://markets.buffalonews.com/buffnews/article/gnwcq-2022-12-5-saratoga-investment-corp-prices-public-offering-of-525-million-8125-notes-due-2027" ["image_url"]=> NULL ["source"]=> string(15) "buffalonews.com" ["publication_date"]=> string(10) "2022-12-05" ["categories"]=> array(1) { [0]=> string(12) "Going Public" } } [3]=> array(7) { ["title_en"]=> string(86) "Saratoga Investment Corp. Prices Public Offering of $40.0 Million 8.00% Notes Due 2027" ["snippet_en"]=> string(190) "NEW YORK, NY , Oct. 19, 2022 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (the “Company”) (NYSE: SAR) today announced that it has priced an underwritten public offering of $40.0 million" ["url"]=> string(169) "https://www.bakersfield.com/ap/news/saratoga-investment-corp-prices-public-offering-of-40-0-million-8-00-notes-due-2027/article_9055086d-a86b-5b32-a3e7-b4c7d33b34a6.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2d62b2bb-7044-4858-8d3e-378b126e8b6f" ["source"]=> string(15) "bakersfield.com" ["publication_date"]=> string(10) "2022-10-19" ["categories"]=> array(2) { [0]=> string(18) "General Investment" [1]=> string(12) "Going Public" } } [4]=> array(7) { ["title_en"]=> string(73) "Accelerate Diagnostics Announces Proposed Public Offering of Common Stock" ["snippet_en"]=> string(162) "/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) ("Accelerate Diagnostics") today announced that it has commenced an underwritten public offering of..." ["url"]=> string(129) "https://www.prnewswire.com/news-releases/accelerate-diagnostics-announces-proposed-public-offering-of-common-stock-301608051.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/571237d8-c530-48a7-a2fc-24a9743ff0a8" ["source"]=> string(14) "prnewswire.com" ["publication_date"]=> string(10) "2022-08-17" ["categories"]=> array(1) { [0]=> string(12) "Going Public" } } [5]=> array(7) { ["title_en"]=> string(50) "Ares Capital Corporation Announces Public Offering" ["snippet_en"]=> string(150) "Ares Capital Corporation (Nasdaq: ARCC) announced that it plans to make a public offering of 8,000,000 shares of its common stock. Ares Capital also p" ["url"]=> string(107) "https://www.businesswire.com/news/home/20220728006042/en/Ares-Capital-Corporation-Announces-Public-Offering" ["image_url"]=> string(78) "https://images.businessradar.com/articles/1cc38917-5c01-4868-8234-5ba0e3ac3c71" ["source"]=> string(16) "businesswire.com" ["publication_date"]=> string(10) "2022-07-28" ["categories"]=> array(3) { [0]=> string(18) "General Investment" [1]=> string(14) "Issuing Shares" [2]=> string(12) "Going Public" } } [6]=> array(7) { ["title_en"]=> string(95) "Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from ..." ["snippet_en"]=> string(206) "NEW YORK, NY, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (the “Company”) (NYSE: SAR) announced the commencement of a registered public offering of unsecured notes (the “Notes”). The" ["url"]=> string(165) "https://www.elpasoinc.com/saratoga-investment-corp-announces-offering-of-notes-and-bbb-investment-grade-rating-from/article_2cc50ca7-8c43-5206-8adf-c4ced9ecba7a.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c7745aca-ec3a-4d40-935f-e7af0a195d01" ["source"]=> string(13) "elpasoinc.com" ["publication_date"]=> string(10) "2022-07-08" ["categories"]=> array(1) { [0]=> string(12) "Going Public" } } [7]=> array(7) { ["title_en"]=> string(95) "Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from ..." ["snippet_en"]=> string(204) "NEW YORK, NY , April 18, 2022 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (the “Company”) (NYSE: SAR) announced the commencement of a registered public offering of unsecured notes (the “Notes”)." ["url"]=> string(183) "https://www.bdtonline.com/news/nation_world/saratoga-investment-corp-announces-offering-of-notes-and-bbb-investment-grade-rating-from/article_e550b970-37f7-563f-9298-cc91c597f339.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/096b0e40-81c4-4066-9b07-5d925b9e77bc" ["source"]=> string(13) "bdtonline.com" ["publication_date"]=> string(10) "2022-04-18" ["categories"]=> array(1) { [0]=> string(12) "Going Public" } } [8]=> array(7) { ["title_en"]=> string(95) "Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering" ["snippet_en"]=> string(246) "Soleno Therapeutics Announces Pricing of Approximately$ 15 Million Underwritten Public Offering[ March 29, 2022] Soleno Therapeutics Announces Pricing of Approximately$ 15 Million Underwritten Public Offering REDWOOD CITY, Calif., March 29, 2022(" ["url"]=> string(131) "https://www.tmcnet.com/usubmit/-soleno-therapeutics-announces-pricing-approximately-15-million-underwritten-/2022/03/29/9572323.htm" ["image_url"]=> NULL ["source"]=> string(10) "tmcnet.com" ["publication_date"]=> string(10) "2022-03-29" ["categories"]=> array(1) { [0]=> string(12) "Going Public" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(55) } [1]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(37) } [2]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(27) } [3]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(16) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(16) } [5]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(12) } [6]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(10) } [7]=> array(2) { ["name"]=> string(25) "Leadership and Governance" ["count"]=> int(7) } [8]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(5) } [9]=> array(2) { ["name"]=> string(15) "Corporate Fines" ["count"]=> int(4) } [10]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(3) } [11]=> array(2) { ["name"]=> string(5) "Fraud" ["count"]=> int(3) } [12]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(3) } [13]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(3) } [14]=> array(2) { ["name"]=> string(5) "Debts" ["count"]=> int(2) } [15]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(2) } [16]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(2) } [17]=> array(2) { ["name"]=> string(17) "Commodity Pricing" ["count"]=> int(2) } [18]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(2) } [19]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(2) } [20]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(1) } [21]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(1) } [22]=> array(2) { ["name"]=> string(12) "Restatements" ["count"]=> int(1) } [23]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(1) } [24]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(1) } [25]=> array(2) { ["name"]=> string(12) "Slash Prices" ["count"]=> int(1) } [26]=> array(2) { ["name"]=> string(5) "SPACs" ["count"]=> int(1) } [27]=> array(2) { ["name"]=> string(10) "Tax Havens" ["count"]=> int(1) } [28]=> array(2) { ["name"]=> string(8) "Accident" ["count"]=> int(1) } [29]=> array(2) { ["name"]=> string(9) "Valuation" ["count"]=> int(1) } } } d9d67-us-oppenheimer-holdings-inc